| 镍钛Smart支架系统治疗重度动脉粥样硬化性颈动脉狭窄：回顾性非随机对照临床试验方案 |
| |
| 引用本文： | 马志刚,孙玉衡,彭晓新,胡洪涛. 镍钛Smart支架系统治疗重度动脉粥样硬化性颈动脉狭窄：回顾性非随机对照临床试验方案[J]. 中国组织工程研究, 2016, 20(30): 4554-4560. DOI: 10.3969/j.issn.2095-4344.2016.20.021 |
| |
| 作者姓名： | 马志刚 孙玉衡 彭晓新 胡洪涛 |
| |
| 作者单位： | 北京积水潭医院神经内科，北京市 100035 |
| |
| 基金项目： | 首都医学发展科研基金资助项目(2003-1002) |
| |
| 摘 要： |
|
| 关 键 词： | 生物材料 材料相容性 临床试验 颈动脉狭窄 Smart支架 镍钛支架系统 动脉粥样硬化 非随机对照试验 |
| 收稿时间： | 2016-05-15 |
Use of the Smart nitinol stent system for the treatment of severe atherosclerotic carotid stenosis: study protocol for a retrospective non-randomized controlled trial |
| |
| Ma Zhi-gang,Sun Yu-heng,Peng Xiao-xin,Hu Hong-tao. Use of the Smart nitinol stent system for the treatment of severe atherosclerotic carotid stenosis: study protocol for a retrospective non-randomized controlled trial[J]. Chinese Journal of Tissue Engineering Research, 2016, 20(30): 4554-4560. DOI: 10.3969/j.issn.2095-4344.2016.20.021 |
| |
| Authors: | Ma Zhi-gang Sun Yu-heng Peng Xiao-xin Hu Hong-tao |
| |
| Affiliation: | Department of Neurology, Beijing Jishuitan Hospital, Beijing 100035, China |
| |
| Abstract: | BACKGROUND: The self-expanding Smart nitinol stent system is a popular treatment for carotid artery stenosis, because it is easy to manipulate and deploy, and endothelialization is rapid.OBJECTIVE: To assess the efficacy of Smart nitinol stent system for the treatment of severe atherosclerotic carotid stenosis.METHODS: We conducted a retrospective, single-center, non-randomized, parallel controlled trial. A cohort of 103 patients with severe atherosclerotic carotid stenosis was included in the analysis after obtaining written informed consent from participants or their guardians. Treatment was undertaken according to each patient’s wishes after weighing the options: a Smart nitinol stent system (Cordis Corporation, Miami, FL, USA) was used in 40 patients, while 63 were managed conservatively with antiplatelet drugs. The primary outcome is the degree of disability of dependence 2 years after treatment, assessed by the modified Rankin Scale. The secondary outcomes are mRS scores 90 days and 1 year after treatment, recurrence of cerebrovascular events, and severity of neurologic deficit measured using the National Institutes of Health Stroke Scale 1 and 2 years after treatment. The study protocol was approved by the Ethics Committee of Beijing Jishuitan Hospital, China (approval number: 201605-01) and conducted in accordance with the guidelines of the Declaration of Helsinki, formulated by the World Medical Association. This trial was registered at ClinicalTrial.gov (NCT02800174).DISCUSSION: Previous studies of the Smart nitinol stent system for the treatment of carotid stenosis are mostly self-controlled case series or small cohort studies with short follow-up periods. Consequently, the long-term influence of Smart nitinol stent deployment on the risk of cerebrovascular events and long-term outcomes are not known. This trial illuminates the therapeutic benefits of the Smart nitinol stent system in a 2-year follow-up study involving a large cohort of patients with severe atherosclerotic carotid stenosis. |
| |
| Keywords: | Clinical Trial Carotid Stenosis Stents Atherosclerosis |
|
| 点击此处可从《中国组织工程研究》浏览原始摘要信息 |
|
点击此处可从《中国组织工程研究》下载全文 |
|
